This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Leukos Biotech, S.l.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations of Enrique Llaudet Carles
Introduction
Enrique Llaudet Carles is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on solid crystalline forms of pharmaceutical compositions.
Latest Patents
One of his key patents is titled "Apomorphine-palmitic acid cocrystal solid particle crystalline form." This patent describes a pharmaceutical composition that comprises apomorphine (APO) in a solid crystalline form. The solid crystalline form is specifically an APO·palmitic acid cocrystal solid particle crystalline form. This innovation has the potential to enhance the delivery and efficacy of apomorphine in medical applications.
Career Highlights
Enrique Llaudet Carles is currently associated with Leukos Biotech, S.L., where he continues to advance his research and development efforts. His work at this company reflects his commitment to improving pharmaceutical formulations and patient outcomes.
Collaborations
He collaborates with talented professionals in the field, including Nicolas Tesson and Montserrat Trilla Castaño. These collaborations enhance the innovative capacity of his projects and contribute to the success of their shared goals.
Conclusion
Enrique Llaudet Carles is a prominent inventor whose work in pharmaceutical compositions is paving the way for advancements in drug delivery systems. His contributions are significant in the realm of innovation and will likely have a lasting impact on the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile